462510 — Lameditech Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩60bn
- KR₩62bn
- KR₩7bn
Annual cashflow statement for Lameditech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | KAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1,867 | -4,430 | -8,305 | -9,484 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 295 | 1,337 | 4,916 | 238 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -252 | -529 | -667 | -1,025 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Net Change in Other Assets & Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -1,823 | -3,387 | -3,760 | -9,807 |
| Capital Expenditures | -198 | -314 | -156 | -4,387 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -5.05 | -69.2 | -4,002 | 63.8 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -203 | -384 | -4,159 | -4,323 |
| Financing Cash Flow Items | 17.2 | 1,542 | -6.39 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 5,353 | 1,573 | 6,293 | 19,688 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 3,327 | -2,203 | -1,630 | 5,560 |